Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

UK pharma: getting ahead of the Brexit debate

As the UK's EU membership referendum looms on the horizon, what could a British exit mean for UK pharma companies? Law firm Hogan Lovells has warned that heavily regulated sectors such as pharmaceuticals could face serious implications, and advises that the industry should make its views clear before the debate kicks off in earnest.

Go Top